Prakt. lékáren. 2010; 6(6): 282-284

Chronic daily headache and it's treatment

MUDr.Ingrid Niedermayerová
Neurologická ambulance Quattromedica Brno a Neurologická klinika LF MU a FN Brno

Chronic daily headache (CDH) represents a heterogenous group including both primary and secondary headaches resulting from various

organic causes. Primary CDH results from chronification of migraine, tension headache or cluster headache. It is often associated with

overuse of analgetics or other acute medications, or with depression and anxiety. Treatment depends on the underlying type of headache

and present complications. Serious conditions require hospitalization.

Keywords: chronic daily headache, medication overuse, triptans, analgetics, depression

Published: December 30, 2010  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Niedermayerová I. Chronic daily headache and it's treatment. Pharmacy for Practice. 2010;6(6):282-284.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Bigal EB, Tepper ST, Sheftell FD, Rapoport AM, Lipton RB. Chronic daily headache: Correlation between the 2004 and the 1988 International Headache Society diagnostic criteria. Headache 2004; 44: 684-691. Go to PubMed...
    2. Saper JR, Dodick D, Gladstone JP. Management of chronic daily headache: Challenges in clinical practice. Headache 2005; 45(Suppl 1): 74-85. Go to original source... Go to PubMed...
    3. The International Classification of Headache Disorders. 2nd Edition. Cephalalgia 2004; 24(Suppl 1): 1-160.
    4. Sun-Edelstein C, Bigal ME, Rapoport AM. Chronic migraine and medication overuse headache: clarifying the current International Headache Society classification criteria. Cephalalgia 2008; 29: 445-452. Go to original source... Go to PubMed...
    5. Relja G, Granato A, Antonello RD, Zorzon M. Headache induced by chronic substance use: Analysis of medication overused and minimum dose required to induce headache. Headache 2004; 44: 148-153. Go to original source... Go to PubMed...
    6. Marková J. Komorbidity migrény. Neurol pro praxi 2005; 5: 248-250.
    7. Katsarava Z, Muessig, Dzagnidze A, Fritsche G, Diener HC. Medication overuse headache: rates and predictors for relapse in a 4-year prospective study. Cephalalgia 2004; 25: 12-15. Go to original source... Go to PubMed...
    8. Waberžinek G. Bolesti hlavy. Praha: Triton, 2000: 192.
    9. Mastík J. Migréna. Praha: Maxdorf, 2007: 104.
    10. Evers S, Áfra J, Frese A, Goadsby PJ, Linde M, May A, Sándor PS. EFNS guideline on the drug treatment of migraine - report of an EFNS task force. European Journal of Neurology 2006; 13: 560-572. Go to original source... Go to PubMed...
    11. Češková E. Duálně působící antidepresiva. Remedia 2006; 16: 594-597.
    12. Bendtsen L, Jensen R. Mirtazapine is effective in the prophylactic treatment of chronic tension type headache. Neurology 2004; 62: 1706-171. Go to original source... Go to PubMed...
    13. Silberstein DS, Lipton BR, Dalessio JD. Wolff´s headache and other head pain. New York: Oxford University Press 2001: 247-282.
    14. Hagen K, Albretsen C, Vilming ST, Salvesen R, Gronning M, et al. Managment of medication overuse headache: 1-year randomized open-label trial. Cephalalgia 2009; 2: 221-232. Go to original source... Go to PubMed...
    15. Marková J, Mastík J, Doležil D, Dočekal P, Niedermayerová I, Rejda J, Kotas R, Lánská V. Nadužívání léků u pacientů s bolestmi hlavy v ČR. Cesk Slov Neurol N 2010 v tisku.

    Return to the content


    Pharmacy for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.